Predicine, Inc. Sustainability Profile
Predicine, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across key regions globally. Founded in 2015, the company has rapidly established itself as a pioneer in genomic profiling and liquid biopsy technologies, focusing on oncology and other critical health areas. Predicine's core offerings include advanced genomic testing services and innovative biomarker solutions that enable personalised treatment strategies for cancer patients. What sets Predicine apart is its commitment to integrating comprehensive genomic data with clinical insights, enhancing the accuracy of diagnostics and therapeutic decisions. With a strong market position, Predicine has achieved notable milestones, including collaborations with major pharmaceutical companies and contributions to groundbreaking research in cancer treatment. The company continues to drive advancements in precision medicine, making significant strides in improving patient outcomes.
DitchCarbon Score
How does Predicine, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Predicine, Inc.'s score of 18 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Predicine, Inc.'s reported carbon emissions
Predicine, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Predicine may not have established formal commitments to reduce its carbon footprint or may be in the early stages of developing such initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific emissions data or reduction initiatives, it is unclear how Predicine aligns with these industry standards. As the company progresses, it may consider implementing strategies to measure and reduce its carbon emissions, thereby contributing to broader climate action efforts.
How Carbon Intensive is Predicine, Inc.'s Industry?
How Carbon Intensive is Predicine, Inc.'s Location?
Predicine, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Predicine, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
